Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

204 Views

Poster Session: Skin and Soft Tissue

1385 - Pathway with single-dose long-acting intravenous antibiotic dalbavancin is a cost-saving alternative to usual inpatient care of acute bacterial skin and skin structure infections (ABSSSI)

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

FL

FRANK LOVECCHIO, DO, MPH

Frank LoVecchio, DO, MPH, Medical Director Clinical Research
Arizona State University, University of AZ and Creighton College of Medicines
PHOENIX, Arizona, United States
AH

Alasdair D. Henry, PhD

Genesis Research
Newcastle Upon Tyne, England, United Kingdom
QD

Quan V. Doan, PharmD

Genesis Research
Hoboken, New Jersey, United States
JL

John L. Lock, PharmD

Assistant Scientific Director
AbbVie Inc
Mettawa, Illinois, United States
RL

Rosie D. Lyles, MD, MHA, MSc

Medical Director
AbbVie
Evanston, Illinois, United States

Presenting Author(s)

XY

Xiaolan Ye, PhD

Director of Health Economics and Outcomes Research
AbbVie Inc.
Mettawa, Illinois, United States